Share

Pancreatic Cancer ‘Time Machine’ Reveals Heterogeneous Nature of the Disease

A pancreatic cancer “time machine” has revealed that the disease is even more unpredictable than previously thought: Cancer cells promote each other’s invasiveness when they grow together, according to a paper recently published in Small. Researchers led by Stephen Konieczny, PhD, professor of biological sciences at Purdue University, and Bumsoo Han, PhD, professor of biomedical...
Share

AFTERMATH: What Happens Next After Thyroid Cancer Treatment?

EN_0120_US_cover The challenges of managing thyroid cancer patients include regulating their hormone replacement therapy and monitoring for recurrence. Here, we highlight an upcoming ENDO 2020 session that details the issues in treating patients post-thyroid cancer therapy. Thyroid cancer patients generally have an excellent prognosis but require careful management to optimize their care. Some strategies for optimizing...
Share

Olaparib Approved in the US as a First-Line Maintenance Treatment of Germline BRCA-mutated Metastatic Pancreatic Cancer

The country was saddened to learn over the weekend that Rep. John Lewis (D-Ga.), the legendary Civil Rights activist, was being treated for stage four pancreatic cancer. “While I am clear-eyed about the prognosis, doctors have told me that recent medical advances have made this type of cancer treatable in many cases, that treatment options...
Share

Case Study Illuminates Metreleptin’s Possible Role in Improving Lipid and Glycemic Profiles

Researchers in Japan have detailed a case report in which a young woman who survived childhood cancer was treated with metreleptin supplementation to improve her acquired incomplete lipodystrophy and published their findings in the Journal of the Endocrine Society. The researchers, led by Ayako Nagayama, MD, and Kenji Ashida, MD, PhD, (Nomura Laboratory) of Kurume...
Share

Researchers Identify Role of ATP-Binding Cassette Transporters in Anaplastic Thyroid Cancer Resistance to Chemotherapy

ATP-binding cassette (ABC) transporters are the major determinants of anaplastic thyroid cancer (ATC) resistance to chemotherapy, and these transporters could be key in tailoring treatments for patients with ATC, according to a paper recently published in Endocrinology. Researchers led by Vahid Haghpanah, MD, MPH, PhD, of the Endocrinology and Metabolism Research at the Tehran University...
Share

ENDO 2019: Teresa Woodruff Charts the History of Reproductive Transplants in Sawin Lecture

teresa in the lab The 2019 Delbert A. Fisher Award recipient is Teresa K. Woodruff, PhD, dean of The Graduate School and Chief of Reproductive Biology Research in the Department of Obstetrics and Gynecology at Northwestern University in Chicago. Each year, the Delbert A. Fisher Research Scholar Award provides a $2,000 honorarium to a scholar demonstrating exceptional work in...

Neoplasia and Cancer Resources

Neoplasia, including both cancers and benign conditions, requires prompt and accurate diagnosis — and treatment — to preserve life and comfort. In the field of endocrinology, neoplasia is a serious concern.

Endocrine neoplasia, whether or not it is cancerous, can throw the entire endocrine system out of balance. So doctors and patients alike need a source for up-to-date information about neoplasia in the endocrine field. Endocrine News has collected all of the articles and information you need about neoplasia, cancer and the endocrine system, and showcased them in one convenient location where both doctors and patients can get the information they need to make informed treatment decisions.

Updated Information About New Treatments and Therapies

On the Neoplasia and Cancer page, you will find articles highlighting promising new therapies and treatments, including pertinent research studies that highlight the effectiveness of these up-and-coming therapies. By staying current with these insights and changes in the field, doctors will be able to offer their patients the best possible solutions for their conditions, and patients will be able to research the top treatment options on their own.

Case Studies in the Neoplasia and Cancer Field

An important part of the resources found on this page is the case studies. By reading real-life case studies relating to cancer and other neoplasia conditions, you will be able to understand the impact of these diseases and their potential treatments on real patients. Case studies also help patients and doctors see what cancer and neoplasia symptoms look like in daily life.

Health Warnings and Advice

The resources on this page provide pertinent health warnings and advice to help patients avoid cancer and tumor risks. By staying informed, both doctors and their patients can help encourage healthier habits to limit the risk of developing neoplasia symptoms and cancer. These warnings and advice articles are specific to endocrine neoplasia conditions.